No Data
No Data
shanghai sanyou medical co., ltd (688085.SH) Supervisor Fang Ying received a warning letter from the Shanghai Securities Regulatory Bureau.
shanghai sanyou medical co., ltd (688085.SH) announced that Ms. Fang Ying, a company supervisor, recently received a notice issued by the Shanghai Securities Regulatory Bureau...
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Shanghai Sanyou Medical Co., Ltd. (688085.SH) released its semi-annual performance, with a net income of 1.68 million yuan, a year-on-year decrease of 97.34%.
shanghai sanyou medical co., ltd (688085.SH) disclosed the 2024 interim report, during the reporting period, the company achieved revenue of 2.12...
Shanghai Sanyou Medical Co., Ltd. (688085.SH): The net income for the first half of the year was 1.6761 million yuan, a year-on-year decrease of 97.34%.
Shanghai Sanyou Medical Co., Ltd. (688085.SH) announced its semi-annual report for 2024, with operating revenue of 0.212 billion yuan, a year-on-year decrease of 24.86%; net income attributable to shareholders of listed companies was 1.6761 million yuan, a year-on-year decrease of 97.34%; basic earnings per share was 0.01 yuan.
Shanghai Sanyou Medical Co., Ltd (688085.SH): intends to directly and indirectly acquire the remaining 48.1846% equity of Shuimu Tianpeng.
Shanghai Sanyou Medical Co., Ltd. (688085.SH) announced on August 14 that it plans to purchase 37.1077% equity of Shuimu Tianpeng held by Cao Qun and Xu Nong by issuing shares and paying cash, and to purchase 98.9986% LP contribution of Shanghai Huanzhan held by Zhan Songtao, Li Chunyuan, Hu Xiaogang, Wang Xiaoling, Feng Zhen, Dai Zhiling, Liu Qingming, Xu Nong, Yue Zhiyong, Shao Huajiang, and Lv Qinying, through a wholly-owned subsidiary TOTEMS Suzhou by paying cash. It also plans to purchase 1.0014% GP contribution of Shanghai Huanzhan held by Tianpeng Investment through TOTEMS Suzhou by paying cash, and issue shares to no more than 35 specific investors to raise matching funds.
No Data